Luddism! I dont think so.

This piece in the The Times earlier this year caught my eye. It's an interesting Pharmaceutical Industry perspective on the transition we are starting to see in prescribing. The fact is that over the next five to ten years many of the biggest "blockbuster" molecules come off patent and the Industrys' pipeline of new molecules to replace them is thin to say the least.

(Click on the image, then click on the "expand" icon that appears on the bottom RHS of the image to get to a readable version)